Pharma considers alternatives to large sales forces
2024-02-27
When Courtney Ness worked as a sales rep for Forest Pharmaceuticals in the early 2000s, she sold the antidepressant Lexapro as part of a 3,000-person sales force.
Her top priority was Lexapro, and she and her teammate called on the same set of doctors.
During a typical month, Ness would talk to a doctor about Lexapro one week, and her teammate would do the same two weeks later. A set of “secondary” sales reps covered the remaining weeks. If all four reps got in, every accessible doctor on the list heard a Lexapro message once a week.
Preview
来源: EndPoints
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
SIGN UP
LOG IN
BECOME A PREMIUM SUBSCRIBER
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
适应症
-靶点
-药物
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。